Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06367894Recruiting

Treatment Optimization and Nephrolithiasis Recurrence Prevention With Interdisciplinary Care

Role: lead

NCT04243772Completed

Metabolic Risk Factors and Stones Composition in Adult Kidney Stone Formers

Role: lead

NCT04770506Completed

Bone Mineral Density and Vascular Calcifications in the Population of Lithiasis Patients With Idiopathic Hypercalciuria

Role: lead

NCT03918824Completed

Influence of Iodinated Contrast Volume Injected During Coronarography on Contrast Nephropathy.

Role: lead

All 4 trials loaded